Understanding why some cervical cancer patients in Nigeria miss a key treatment

Most women fighting cervical cancer need brachytherapy—a targeted radiation method—to fully beat the disease. But this treatment isn’t always easy to find, especially in poorer nations. Nigeria has one of Africa’s busiest cancer centers, yet many patients still miss out on this life-saving option. Researchers wanted to know why. They dug into hospital records to see which patients got the treatment and which ones didn’t. What they found wasn’t surprising: brachytherapy is hard to deliver. It needs special machines, skilled doctors, and careful planning. In places with limited funds, that kind of setup is rare. The study uncovered another issue—many women simply don’t finish the treatment they start. Some face long travel times, high costs, or don’t even know this option exists.The team also spotted a few key factors that affect who actually gets the therapy. Younger women and those with earlier-stage cancer were more likely to receive it. But older patients or those with more advanced disease often got less access. Education played a role too—women who knew more about cancer treatments were more likely to push for brachytherapy. This isn’t just about Nigeria. Across many low- and middle-income countries, brachytherapy remains out of reach for thousands. The treatment works, but the system often doesn’t support it. Until better funding and training arrive, too many women will keep missing out on a cure they deserve.